Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04907825 · ClinicalTrials.gov registry record · Phase 4
A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT04907825 is a Phase 4 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT04907825, a Phase 4 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a prospective, single-arm, feasibility pilot study of 20 participants (aged 60 years or older, with additional stroke risk factors and 'actionable' undertreated AF) recruited from a total of 4 retail and outpatient community pharmacies. Eligible participants will be enrolled in a 3-month active intervention of pharmacist-led OAC management. Participants will be passively followed for an additional 9 months to determine safety endpoints.
Interventions
- DRUG Oral anticoagulant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2026-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04907825
The ClinicalTrials.gov registry entry for NCT04907825 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral anticoagulant is the first listed.
NCT04907825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04907825 about?
NCT04907825 is a clinical study titled "A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF". This is a prospective, single-arm, feasibility pilot study of 20 participants (aged 60 years or older, with additional stroke risk factors and 'actionable' undertreated AF) recruited from a total of 4 retail and outpatient community pharmacies. Eligible participants will be enrolled in a 3-month act...
What is the current status of trial NCT04907825?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2023-03-13. Estimated completion is 2026-01-31.
What interventions are being tested in trial NCT04907825?
The interventions under investigation include: Oral anticoagulant (DRUG).
Who is sponsoring clinical trial NCT04907825?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.